BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Drug Development

  Novartis’ Autoimmune Drug Not Up for the Challenge in Phase III Cancer Trial

  The drug was being evaluated in 237 adults with locally advanced or metastatic non-small cell lung cancer whose disease progressed while on or after previous platinum-based chemotherapy and checkpoint inhibitor immunotherapy.

  March 9, 2021

   · 

  3 min read

   · 

  Mark Terry
• 

  Genetown

  New Drug Approval Could Be on Horizon for Alzheimer’s after 17-Year Drought

  A drug to halt the progression of Alzheimer’s disease will likely be approved within the next three years, and Alzheon’s ALZ-801 might be the leading candidate.

  March 9, 2021

   · 

  5 min read

   · 

  Gail Dutton
• 

  Business

  New CDC Guidance for Fully Vaccinated People Brings Hope (and Criticism)

  In the wake of an increasingly accelerated COVID-19 vaccine rollout, the CDC has released new guidance statements that give fully vaccinated individuals more freedom to socialize and participate in pre-pandemic activities.

  March 9, 2021

   · 

  3 min read

   · 

  Brandon May
• 

  Business

  Money on the Move – March 3-9

  Money flows into life sciences companies on a daily basis. Here’s who’s celebrating this week.

  March 9, 2021

   · 

  4 min read

   · 

  Kate Goodwin
• 

  Business

  Industry Veterans Jump Ship in Favor of Smaller Biotechs

  It didn’t take long for Jason Campagna to find a new role after departing Intercept Pharmaceuticals last month. Campagna will take on the role of chief medical officer for Q32 Bio.

  March 9, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  Business

  Promoting Diversity & Inclusion Through an Ethos of Cultural and Emotional Intelligence

  Despite a historic push for greater diversity and inclusion (D&I), a significant disconnect prevails between good intentions and actual lived experiences.

  March 9, 2021

   · 

  6 min read

   · 

  Heather McKenzie
• 

  CARB-X Places $22 Million Bet on Affinivax Staph Vaccine

  Less than two months after bacterial vaccine company Affinivax’s Series C financing, the company is getting a $22 million boost from infectious disease consortium CARB-X to push forward a vaccine for tough-to-treat preclinical Staphylococcus aureus

  March 9, 2021

   · 

  2 min read

   · 

  Mark Zipkin
• 

  Pharm Country

  COVID News: Pfizer-BioNTech Vaccine Effective Against Brazilian Variant and More

  There was a little bit of positive COVID-19 news to report today. Here’s a look.

  March 9, 2021

   · 

  2 min read

   · 

  Mark Terry
• 

  Drug Development

  2021 Biopharma Update on the Novel Coronavirus: March 9

  Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for March 9, 2021.

  March 9, 2021

   · 

  5 min read

   · 

  BioSpace Editorial Staff
• 

  Potential Blockbuster Drugs for 2021 – Alzheimer’s, Prostate Cancer and More

  Clarivate published its annual “Drugs to Watch” list, and cited four drugs that it expects to be blockbusters—projected to bring in $1 billion in sales annually.

  March 9, 2021

   · 

  5 min read

   · 

  Mark Terry